Multimodality Imaging in Cardiac Amyloidosis
Journal of Clinical Medicine · 25.12.2025 · 15 (1) · 163
DOI: 10.3390/jcm15010163 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 25.12.2025. Verfasst von Mayuresh Chaudhari und 1 weiteren Autor:innen. Beteiligte Einrichtung: UT Health Sciences Centre, Glen Biggs Institute, San Antonio, TX 78229, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiac amyloidosis is an underdiagnosed cause of heart failure characterized by extracellular deposition of misfolded proteins. Advances in non-invasive imaging, including echocardiography, cardiac magnetic resonance imaging (CMR), and radionuclide imaging, have significantly enhanced the diagnostic accuracy and monitoring of cardiac amyloidosis. This review explores the role of each modality, their individual strengths, and current consensus recommendations. Emphasis is placed on the integration of multimodal imaging to guide diagnosis, prognosis, and therapeutic decisions in both AL and ATTR amyloidosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UT Health Sciences Centre, Glen Biggs Institute, San Antonio, TX 78229, USA.
- UHS/UT Heart and Vascular Institute, San Antonio, TX 78229, USA.
ORCID-Profile: Mayuresh Chaudhari
Zitieren
APA
Chaudhari, M., & Ashwath, M. L. (2025). Multimodality Imaging in Cardiac Amyloidosis. Journal of Clinical Medicine, 15(1), 163. https://doi.org/10.3390/jcm15010163
Vancouver
Chaudhari M, Ashwath ML. Multimodality Imaging in Cardiac Amyloidosis. Journal of Clinical Medicine. 2025;15(1):163. doi:10.3390/jcm15010163
BibTeX
@article{Chaudhari2025,
author = {Chaudhari, Mayuresh and Ashwath, Mahi Lakshmi},
title = {Multimodality Imaging in Cardiac Amyloidosis},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {15},
number = {1},
pages = {163},
doi = {10.3390/jcm15010163}
}
EUVIMED